StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) income statement

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 7/30
$270.33−0.86 (-0.32%)

Close on Nov 18, 2026Market cap $16.75BP/E 22.2Yield –

Ascendis Pharma A/S income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
91.3%
Operating margin
25.4%
Net margin
70.8%
Return on equity, FY2025
–

Financial strength

Current ratio
2.99
Debt to equity
–
Debt to assets
16.8%
Cash to current liabilities
174.7%

Valuation

P/E ratio
22.2
Price to sales
14.50
Price to book
–
Dividend yield
–

See a number that looks wrong?